Literature DB >> 32105415

Genomic Stability Testing of Pluripotent Stem Cells.

Erik McIntire1, Seth Taapken2, Kimberly Leonhard2, Anna Lisa Larson2.   

Abstract

Pluripotent stem cell (PSC) cultures are subjected to selective pressures that can result in acquisition and expansion of recurrent genetic abnormalities at any time. These recurrent abnormalities enhance the variant cells harboring them with a competitive advantage over wild-type cells. Variant cells can eventually supplant wild-type cells entirely and become fixed in culture. Such variants can impact the efficacy of PSCs in research and clinical applications. Therefore, routine genomic characterization is required for reliable and effective use of PSCs. In this article we describe the capabilities and limitations of several assays commonly used for assessing PSC genomic stability. Based on this analysis, we provide a recommendation for integrating assays into a comprehensive testing regimen that maximizes coverage while minimizing cost.
© 2020 by John Wiley & Sons, Inc. © 2020 John Wiley & Sons, Inc.

Entities:  

Keywords:  G-banded karyotyping; chromosomal microarray; cytogenomics; fluorescence in situ hybridization; next-generation sequencing; quantitative polymerase chain reaction; recurrent acquired genetic abnormalities

Mesh:

Year:  2020        PMID: 32105415     DOI: 10.1002/cpsc.107

Source DB:  PubMed          Journal:  Curr Protoc Stem Cell Biol        ISSN: 1938-8969


  2 in total

Review 1.  Balancing serendipity and reproducibility: Pluripotent stem cells as experimental systems for intellectual and developmental disorders.

Authors:  Nickesha C Anderson; Pin-Fang Chen; Kesavan Meganathan; Wardiya Afshar Saber; Andrew J Petersen; Anita Bhattacharyya; Kristen L Kroll; Mustafa Sahin
Journal:  Stem Cell Reports       Date:  2021-04-15       Impact factor: 7.765

2.  A call for consensus guidelines on monitoring the integrity of nuclear and mitochondrial genomes in human pluripotent stem cells.

Authors:  Andrea Rossi; Selene Lickfett; Soraia Martins; Alessandro Prigione
Journal:  Stem Cell Reports       Date:  2022-03-03       Impact factor: 7.294

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.